THE EFFECT OF SMOKING ON OUTCOME FOLLOWING EXTERNAL RADIATION FOR LOCALIZED PROSTATE CANCER

Autor: PICKLES, T. ^*, LIU, M., BERTHELET, E., KIM-SING, C., KWAN, W., TYLDESLEY, S.

Publikováno v: In The Journal of Urology 2004 171(4):1543-1546

Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations

Autor: Bordeleau, L, Lipscombe, L, Lubinski, J, Ghadirian, P, Foulkes, Wd, Neuhausen, S, Ainsworth, P, Pollak, M, Sun, P, Narod, Sa, Hereditary Breast Cancer Clinical Study Group Collaborators: Lynch HT, Eisen, A, Mckinnon, W, Wood, M, Saal, H, Chudley, A, Robidoux, A, Kim Sing, C, Tung, N, Armel, S, Huzarski, T, Provencher, D, Lemire, E, Tulman, A, Llacuachaqui, M, Sweet, K, Gilchrist, D, Karlan, B, Kurz, R, Rosen, B, Demsky, R, Panchal, S, Couch, F, Elser, C, Manoukian, S, Daly, M, Cybulski, C, Gronwald, J, Byrski, T, Olapade, O, Stoppa Lyonnet, D, Weitzel, J, Mclennan, J, Meschino, W, Pasini, Barbara, Singer, C, Dressler, C, Metcalfe, K, Domchek, S, Isaacs, C.

Publikováno v: Biochemistry Publications

Women with a BRCA1 or BRCA2 mutation face a high lifetime risk of breast cancer.1 It is important to identify risk factors for breast cancer among genetically predisposed women, to devise strategies to minimize the risk. Several lines of evidence lin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc73859fbe80a163d276de60b6c65557
https://doi.org/10.1002/cncr.25595

The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation

Autor: Valentini, A, Lubinski, J, Byrski, T, Ghadirian, P, Moller, P, Lynch, Ht, Ainsworth, P, Neuhausen, Sl, Weitzel, J, Singer, Cf, Olopade, Oi, Saal, H, Lyonnet, Ds, Foulkes, Wd, Kim Sing, C, Manoukian, S, Zakalik, D, Armel, S, Senter, L, Eng, C, Grunfeld, E, Chiarelli, Am, Poll, A, Sun, P, Narod, Sa, Hereditary Breast Cancer Clinical Study Group: Gronwald, J, Cybulski, C, Huzarski, T, Robidoux, A, Offit, K, Gershoni Baruch, R, Isaacs, C, Tung, N, Rosen, B, Demsky, R, Mccuaig, J, Eisen, A, Bordeleau, L, Karlan, B, Garber, J, Gilchrist, D, Couch, F, Evans, G, Kwong, A, Maehle, L, Friedman, E, Mckinnon, W, Wood, M, Daly, M, Blum, Jl, Robson, M, Chudley, A, Panchal, S, Mclennan, J, Pasini, Barbara, Rennert, G, Lunn, J, Fallen, T, Rayson, D, Smith, M, Ginsburg, O, Lemire, E, Meschino, W, Vadaparampil, S, Euhus, D, Costalas, Jw, Donenberg, T, Kurz, Rn, Friedman, S, Sweet, K, Cullinane, Ca, Reilly, Re, Kotsopoulos, J, Nanda, S, Metcalfe, K.

Publikováno v: Breast cancer research and treatment. 142(1)

Physicians are often approached by young women with a BRCA mutation and a recent history of breast cancer who wish to have a baby. They wish to know if pregnancy impacts upon their future risks of cancer recurrence and survival. To date, there is lit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c98e9254dfa22ee0f61e35630c72ea
https://pubmed.ncbi.nlm.nih.gov/24136669

Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation

Autor: Senst, N, Llacuachaqui, M, Lubinski, J, Lynch, H, Armel, S, Neuhausen, S, Ghadirian, P, Sun, P, Narod, Sa, Hereditary Breast Cancer Study Group: Panchal, S, Rosen, B, Demsky, R, Foulkes, Wd, Kim Sing, C, Singer, C, Short, T, Senter, L, Sweet, K, Tung, N, Ainsworth, P, Eisen, A, Gilchrist, D, Bordeleau, L, Olopade, Oi, Karlan, B, Kurz, R, Couch, F, Manoukian, S, Daly, M, Saal, H, Mckinnon, W, Wood, M, Elser, C, Eng, C, Weitzel, J, Mclennan, J, Lemire, E, Fallen, T, Kaklamani, V, Stoppa Lyonnet, D, Isaacs, C, Rayson, D, Ginsburg, O, Chudley, A, Pasini, Barbara, Zakalik, D, Cullinane, Ca, Pal, T, Vadaparampil, S, Friedman, S, Meschino, W, Moller, P, Maehle, L, Valentini, A, Ragone, A, Poll, A, Nanda, S.

Publikováno v: Clinical genetics. 84(1)

The objective is to estimate the risk of breast cancer in women who carry a deleterious BRCA1 or BRCA2 mutation, according to parental origin of mutation. We conducted a cohort study of women with a BRCA1 mutation (n = 1523) or BRCA2 mutation (n = 36

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::45ba98f9564ce0fe4ad1ec63d3bc68e8
https://pubmed.ncbi.nlm.nih.gov/23066998

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

Autor: Eisen, A, Lubinski, J, Gronwald, J, Moller, P, Lynch, Ht, Klijn, J, Kim Sing, C, Neuhausen, Sl, Gilbert, L, Ghadirian, P, Manoukian, S, Rennert, G, Friedman, E, Isaacs, C, Rosen, E, Rosen, B, Daly, M, Sun, P, Narod, Sa, Hereditary, Breast Cancer Clinical Study Group, Collaborators: Olopade, O, Cummings, S, Tung, N, Couch, F, Foulkes, Wd, Domchek, S, Stoppa Lyonnet, D, Gershoni Baruch, R, Horsman, D, Wagner, T, Saal, H, Warner, E, Meschino, W, Offit, K, Trivedi, A, Robson, M, Osborne, M, Gilchrist, D, Eng, C, Weitzel, J, Mckinnon, W, Wood, M, Maugard, C, Pasini, Barbara, Ainsworth, P, Sweet, K, Pasche, B, Fallen, T, Karlan, B, Kurz, Rn, Armel, S, Tulman, A, Lemire, E, Mclennan, J, Evans, G, Byrski, T, Huzarski, T, Shulman, L.

Publikováno v: The Hereditary Breast Cancer Clinical Study Group 2008, ' Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers ', Journal of the National Cancer Institute, vol. 100, no. 19, pp. 1361-1367 . https://doi.org/10.1093/jnci/djn313
JNCI Journal of the National Cancer Institute
Journal of the National Cancer Institute, 100(19), 1361-1367. Oxford University Press

Background: Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential association of HT and breast cance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e941824d7afe28d1b2af179736d1102
https://pubmed.ncbi.nlm.nih.gov/19211447